IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Rock Springs Capital Management LP

Q4 2023 Holdings

Filed 2024-02-14 | 104 holdings | $4.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Neurocrine Biosciences Inc(NBIX)COM64125C109$157.6M1,196,0003.9%
Karuna Therapeutics IncCOM48576A100$163.0M515,0244.0%
Immunocore Hldgs PLC(IMCR)ADS45258D105$181.8M2,661,5074.5%
Blueprint Medicines Corp(2L9)COM09627Y109$265.8M2,881,5676.5%
PreviousPage 3 of 3